Astrana Health (ASTH) Equity Average (2011 - 2026)

Astrana Health has disclosed Equity Average across 16 years of filings, most recently posting $797.2 million for Q1 2026.

• Equity Average for Q1 2026 came in at $797.2 million, up 8.68% year-over-year; the trailing twelve-month figure through Mar 2026 was $797.2 million (up 8.68% YoY), and the FY2025 annual result was $748.0 million, up 12.2% from the prior year.
• Equity Average came in at $797.2 million for Q1 2026 at Astrana Health, up from $777.4 million in the prior quarter.
• In the past five years, Equity Average ranged from a high of $797.2 million in Q1 2026 to a low of $463.4 million in Q1 2022.
• The 5-year median for Equity Average is $637.3 million (2024), against an average of $636.2 million.
• Across the five-year window, Equity Average surged 36.99% in 2022 and rose 8.68% in 2026, its largest moves.
• Astrana Health's Equity Average stood at $524.3 million in 2022, then advanced by 15.8% to $607.2 million in 2023, then rose by 17.46% to $713.2 million in 2024, then increased by 9.01% to $777.4 million in 2025, then grew by 2.55% to $797.2 million in 2026.
• The last three Equity Average figures came in at $797.2 million (Q1 2026), $777.4 million (Q4 2025), and $773.5 million (Q3 2025), per Business Quant data.